Section
A pioneering study demonstrates that visual cues of infection in virtual reality can trigger real immune activation, revealing a rapid neural-immune interface with potential implications for medicine, psychology, and vaccine development.
AI offers transformative potential for clinical trials, but realizing its value demands a robust, stakeholder-driven framework to guide adoption and assess impact across the trial lifecycle.
This study assesses ChatGPT-4’s effectiveness as a virtual assistant in managing puerperal mastitis, focusing on accuracy, clarity, and safety in patient communication.
The VIDEOGO trial shows that online video consultations are non-inferior to face-to-face consultations for preoperative assessment in major abdominal surgery, achieving similar patient satisfaction and information recall.
Two randomized controlled trials evaluated immersive VR therapies targeting auditory verbal hallucinations and persecutory delusions in schizophrenia and psychosis, revealing modest benefits for hallucinations but no superior effect for cog
Limited demographic data transparency in FDA-authorized AI devices for Alzheimer’s may hinder equitable care and generalizability, highlighting a crucial need for improved dataset representativeness and regulatory oversight.
Systemically biased AI models can reduce clinicians’ diagnostic accuracy, and explanations alone may not mitigate this harm, according to a multicenter study involving over 450 clinicians.
Explore how artificial intelligence is reshaping healthcare, from diagnosis to patient care, and what it means for doctors and patients alike.
Smartwatches are transforming healthcare, from heart monitoring to early disease detection. But are they truly lifesavers—or can they mislead us? Discover the science, the myths, and the future of wearable health tech.
